Literature DB >> 25605753

Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A.

Vanda S Lopes1, David S Williams1.   

Abstract

Usher syndrome is a deaf-blindness disorder. One of the subtypes, Usher 1B, is caused by loss of function of the gene encoding the unconventional myosin, MYO7A. A variety of different viral-based delivery approaches have been tested for retinal gene therapy to prevent the blindness of Usher 1B, and a clinical trial based on one of these approaches has begun. This review evaluates the different approaches.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605753      PMCID: PMC4448706          DOI: 10.1101/cshperspect.a017319

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  48 in total

1.  Myosin VIIa, the product of the Usher 1B syndrome gene, is concentrated in the connecting cilia of photoreceptor cells.

Authors:  X Liu; G Vansant; I P Udovichenko; U Wolfrum; D S Williams
Journal:  Cell Motil Cytoskeleton       Date:  1997

2.  Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.

Authors:  H Miyoshi; M Takahashi; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier.

Authors:  O Grüter; C Kostic; S V Crippa; M-T R Perez; L Zografos; D F Schorderet; F L Munier; Y Arsenijevic
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

4.  Analysis of the linkage of MYRIP and MYO7A to melanosomes by RAB27A in retinal pigment epithelial cells.

Authors:  Adriana E Klomp; Karen Teofilo; Erin Legacki; David S Williams
Journal:  Cell Motil Cytoskeleton       Date:  2007-06

5.  Characterization of genome integrity for oversized recombinant AAV vector.

Authors:  Biao Dong; Hiroyuki Nakai; Weidong Xiao
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

6.  Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein.

Authors:  Daniel Gibbs; Junko Kitamoto; David S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

7.  Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.

Authors:  J Kong; S-R Kim; K Binley; I Pata; K Doi; J Mannik; J Zernant-Rajang; O Kan; S Iqball; S Naylor; J R Sparrow; P Gouras; R Allikmets
Journal:  Gene Ther       Date:  2008-05-08       Impact factor: 5.250

8.  Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B.

Authors:  T Hashimoto; D Gibbs; C Lillo; S M Azarian; E Legacki; X-M Zhang; X-J Yang; D S Williams
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 4.184

9.  Myosin7a deficiency results in reduced retinal activity which is improved by gene therapy.

Authors:  Pasqualina Colella; Andrea Sommella; Elena Marrocco; Umberto Di Vicino; Elena Polishchuk; Marina Garcia Garrido; Mathias W Seeliger; Roman Polishchuk; Alberto Auricchio
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

10.  Localization of Usher 1 proteins to the photoreceptor calyceal processes, which are absent from mice.

Authors:  Iman Sahly; Eric Dufour; Cataldo Schietroma; Vincent Michel; Amel Bahloul; Isabelle Perfettini; Elise Pepermans; Amrit Estivalet; Diane Carette; Asadollah Aghaie; Inga Ebermann; Andrea Lelli; Maria Iribarne; Jean-Pierre Hardelin; Dominique Weil; José-Alain Sahel; Aziz El-Amraoui; Christine Petit
Journal:  J Cell Biol       Date:  2012-10-08       Impact factor: 10.539

View more
  4 in total

1.  Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.

Authors:  Da Sun; Rebecca M Schur; Avery E Sears; Song-Qi Gao; Amita Vaidya; Wenyu Sun; Akiko Maeda; Timothy Kern; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

2.  Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.

Authors:  Lijuan Zhang; Sally Justus; Yu Xu; Tamara Pluchenik; Chun-Wei Hsu; Jin Yang; Jimmy K Duong; Chyuan-Sheng Lin; Yading Jia; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Hum Mol Genet       Date:  2016-08-11       Impact factor: 6.150

Review 3.  How Transmembrane Inner Ear (TMIE) plays role in the auditory system: A mystery to us.

Authors:  Mohammad Farhadi; Ehsan Razmara; Maryam Balali; Yeganeh Hajabbas Farshchi; Masoumeh Falah
Journal:  J Cell Mol Med       Date:  2021-05-13       Impact factor: 5.310

Review 4.  Toward an elucidation of the molecular genetics of inherited retinal degenerations.

Authors:  G Jane Farrar; Matthew Carrigan; Adrian Dockery; Sophia Millington-Ward; Arpad Palfi; Naomi Chadderton; Marian Humphries; Anna Sophia Kiang; Paul F Kenna; Pete Humphries
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.